Xtant Medical is a medical devices business based in the US. Xtant Medical shares (XTNT) are listed on the NYSE MKT and all prices are listed in US Dollars. Its last market close was $0.50 – an increase of 2.53% over the previous week. Xtant Medical employs 217 staff and has a trailing 12-month revenue of around $117.3 million.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.50 |
|---|---|
| 52-week range | $0.33 - $0.88 |
| 50-day moving average | $0.47 |
| 200-day moving average | $0.54 |
| Wall St. target price | $1.75 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.12 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.47 from 2025-05-02
| 1 week (2025-04-28) | -2.08% |
|---|---|
| 1 month (2025-04-04) | 0.47 |
| 3 months (2025-02-06) | -21.67% |
| 6 months (2024-11-06) | -11.32% |
| 1 year (2024-05-06) | -46.59% |
|---|---|
| 2 years (2023-05-05) | -24.80% |
| 3 years (2022-05-05) | 0.6008 |
| 5 years (2020-05-05) | 0.72 |
| Revenue TTM | $117.3 million |
|---|---|
| Gross profit TTM | $68.2 million |
| Return on assets TTM | -8.1% |
| Return on equity TTM | -34.88% |
| Profit margin | -14.03% |
| Book value | $0.31 |
| Market Capitalization | $65.8 million |
TTM: trailing 12 months
We're not expecting Xtant Medical to pay a dividend over the next 12 months.
Xtant Medical's shares were split on a 1:12 basis on 13 February 2018 . So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Xtant Medical shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Xtant Medical shares which in turn could have impacted Xtant Medical's share price.
Over the last 12 months, Xtant Medical's shares have ranged in value from as little as $0.33 up to $0.88. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Xtant Medical's is -0.134. This would suggest that Xtant Medical's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Xtant Medical has bucked the trend.
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, which can be compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, the company offers cervical products comprising Spider cervical plating, Streamline OCT, and CervAlign systems; thoracolumbar products consisting of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2. 0 hybrid performance systems; and Silex sacroiliac joint fusion systems. Further, it provides interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain.
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
See our picks for the best brokers for trading S&P 500 stocks, ETFs, options and futures.
Our picks of the best brokerage accounts for index funds for beginners, teens, proprietary funds and more.
These are the stocks to buy when you don’t have much to spend.
Cash sweep accounts let you earn interest on your uninvested cash. Learn how they work and how to choose the best one here.
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
Thinking of switching from Moomoo? Here are 5 apps like Moomoo that offer valuable benefits
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
Webull is a broker with zero-commission trading and a suite of tools to help you invest.